Quick Answer
Marker Therapeutics, Inc. reported Stockholders Equity of $16.80 million for fiscal year 2025.
Marker Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $16.80M | -9.5% |
| 2024 | $18.56M | +32.1% |
| 2023 | $14.05M | -28.3% |
| 2022 | $19.60M | -55.4% |
| 2021 | $43.99M | +60.9% |
| 2020 | $27.34M | -38.0% |
| 2019 | $44.09M | -25.7% |
| 2018 | $59.34M | +1522.2% |
| 2017 | $3.66M | -40.9% |
| 2016 | $6.18M | +129.0% |
| 2015 | -$21.36M | -1986.7% |
| 2014 | -$1.02M | +88.3% |
| 2013 | -$8.77M | -45.1% |
| 2012 | -$6.04M | -74.6% |
| 2011 | -$3.46M | +10.5% |
| 2010 | -$3.87M | -116.9% |
| 2009 | -$1.78M | +41.0% |
| 2008 | -$3.02M | -80.5% |
| 2007 | -$1.67M | +44.2% |
| 2006 | -$3.00M | -35.2% |
| 2005 | -$2.22M | +9.0% |
| 2004 | -$2.44M | -279.1% |
| 2003 | -$643.7K | -238.2% |
| 2002 | $465.8K | +729.1% |
| 2001 | -$74.0K | -129.4% |
| 2000 | $252.2K | +151.3% |
| 1999 | $100.4K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $18.39M | +146.8% | +75.3% |
| June 30, 2025 | $10.49M | +8.1% | -27.6% |
| March 31, 2025 | $14.49M | +22.9% | -21.9% |
| December 31, 2024 | $18.56M | +32.1% | +149.1% |
| September 30, 2024 | $7.45M | -55.4% | -23.2% |
| June 30, 2024 | $9.70M | -49.0% | -17.7% |
| March 31, 2024 | $11.79M | -25.9% | -16.1% |
| December 31, 2023 | $14.05M | -28.3% | -15.9% |
- Marker Therapeutics, Inc. showed a decrease of -9.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 1999–2025 period, Marker Therapeutics, Inc.’s stockholders equity has grown by 16635.4% (from $100.4 thousand to $16.80 million).
- The most recent figure is from Marker Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: